FRCR Part 2A (Oncology) - CO2A

FRCR examinations updates

Please read our lastest examination updates addressing the changes made on all our FRCR examinations from 2020 until our current date. 

April 2021 examination sitting update

The Final FRCR Part A examination in Clinical Oncology will now be after the Part B examination which runs from 17 to 22 April 2021. Priority 1 candidates (UK trainees and all NHS contributors) who applied for the Final FRCR Part A examination in Clinical Oncology in February 2021, that wish to attempt both Part A and Part B will now take the Final FRCR Part B examination first and continue to the Final FRCR Part A examination regardless of the outcome. Priority 2 Final Part A candidates will automatically be moved to the new date in April shown above, but will not be entered for the Final FRCR Part B April examination. 

A pass in the Final FRCR Part A examination will be valid for future attempts at the Final FRCR Part B examination, should they be needed. A candidate who passes the Final FRCR Part B examination but then fails the Final FRCR Part A examination would need to complete Part A examination at a future sitting for the award of FRCR and CCT, but would not need to repeat the Final FRCR Part B examination in Clinical Oncology.

Dual applications for the Final FRCR Part A and Part B examinations in Clinical Oncology 

Following what is stated on the guidance notes for the Final FRCR Part A examination, please note the Final FRCR Part B examination applications are separate; therefore, candidates who wish to apply for the Final Part B examination and the Final Part A (in the same examination sitting), they need to submit an application for each of the examinations separately and within their application window. No late applications are considered and there are no exeptions. Candidates who apply for both examinations in the same sitting will pay for the Final Part B examination fees once they have received their Final Part A results. 


Purpose of assessment

The Final FRCR (Part A) Examination expects candidates to have a wide knowledge of malignant disease and the management of patients with cancer. The main emphasis is on radiotherapy and drug therapy, but a good knowledge of general medicine, surgery and gynaecology is expected. Candidates are examined against the specialty training curriculum for clinical oncology and the clinical oncology syllabus. The Final FRCR (Part A) Examination comprises two papers of 120 single best answer (SBA) questions. Further general information on the examination is available in the guidance notes. Please note that for candidates who are eligible and wish to apply for the Final FRCR (Part B) examination at the same examination sitting of the Final FRCR (Part A) examination, they must apply within the corresponding application date. Once the results of the Final FRCR (Part A) examination are published, the sucssesful candidates will be asked to pay for the Final FRCR (Part B) examination accordingly.  

The Final FRCR Examination purpose of assessment statement details the examination's purpose, the required level of candidate training and the application of results. It is hoped that the statement will assist candidates, and those involved in their training, in understanding the scope of the FRCR examination and with relating the examination to other in-training assessments. 

Before you apply 


Dates and fees

Find out about dates and fees for this exam


How to apply

Applicants should ensure they have read the examination regulations before applying.

Applications for this examination are not currently open


Candidate Resources

The Final Examining Board suggests that candidates prepare for the examination using TNM version 8. The examiners are, however, aware that previous versions remain in common use around the country and will generally use questions where trainees more familiar with TNM version 7 are still able to answer the questions successfully.